2021 Biomedical Technology and Social System I

Font size  SML

Register update notification mail Add to favorite lecture list
Academic unit or major
Graduate major in Technology and Innovation Management
Instructor(s)
Sengoku Shintaro 
Course component(s)
Lecture    (ZOOM)
Day/Period(Room No.)
Sat3-4()  
Group
-
Course number
TIM.C514
Credits
1
Academic year
2021
Offered quarter
3Q
Syllabus updated
2021/3/19
Lecture notes updated
2021/11/6
Language used
Japanese
Access Index

Course description and aims

The biohealthcare industry currently forms a huge market with a wide range of fields and spreads across academic, industry and public sectors.
This lecture course provides the overview of the biohealthcare industry, facilitates discussion on the perspective of strategic planning, R&D and management of related technology elements, and encourages practical learning from representative business cases.

Student learning outcomes

This lecture series aims to provide the overview of biohealthcare industry for corrective understanding of industry structure and dynamics, issues and persiectives.

Course taught by instructors with work experience

Applicable How instructors' work experience benefits the course
This lecture series is conducted by a scholarly practitioner with expertise in research and development, management consulting and venture capital business in the fields of biotechnology and healthcare.

Keywords

Biotechnology, Pharmaceutical and medical products, regenerative medicine, industry structure, corporate management, ecosystem.

Competencies that will be developed

Specialist skills Intercultural skills Communication skills Critical thinking skills Practical and/or problem-solving skills

Class flow

Each industry topic has two classes. The part 1 provides the overview and dynamics of the industry of topic to nurture basic understanding and to discuss current issues and perspectives. The part 2 consists of a case study on firms of interest or a guest lecture by industry experts to discuss implications from the MOT and innovation management viewpoints.

Course schedule/Required learning

  Course schedule Required learning
Class 1 Introduction None
Class 2 Pharmaceutical products: part 1 The overview and dynamics of the industry
Class 3 Pharmaceutical products: part 2 Cases studies of the industry
Class 4 Medical devices: part 1 The overview and dynamics of the industry
Class 5 Medical devices: part 2 Cases studies of the industry
Class 6 Cell & gene therapy: part 1 The overview and dynamics of the industry
Class 7 Cell & gene therapy: part 2 Cases studies of the industry

Out-of-Class Study Time (Preparation and Review)

To enhance effective learning, students are encouraged to spend approximately 100 minutes preparing for class and another 100 minutes reviewing class content afterwards (including assignments) for each class.
They should do so by referring to textbooks and other course material.

Textbook(s)

To be circulated via OCW-i before each class.

Reference books, course materials, etc.

To be provided in every class.

Assessment criteria and methods

Physical attendance, proactive participation in the lectures and the performance of case study practices are considered. Details are to be informed of in the first lecture.

Related courses

  • TIM.C515 : Biomedical Technology and Social System II

Prerequisites (i.e., required knowledge, skills, courses, etc.)

Not required, but taking 'Biomedical Technology and Social System II' (TIM.C515) is desired.

Other

This lecture plan is a model case. Please check the lecture schedule of each academic year.

Page Top